Pictet & Cie (Europe) Sa Becton Dickinson & CO Transaction History

Pictet & Cie (Europe) Sa

$4.53 Billion
Q4 2024

A detailed history of Pictet & Cie (Europe) Sa transactions in Becton Dickinson & CO stock. As of the latest transaction made, Pictet & Cie (Europe) Sa holds 2,000 shares of BDX stock, worth $490,120. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,000

Previous 2,000 -0.0%

Holding current value

$490,120

Previous $482,000 6.02%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$232.24 - $267.23 $464,480 - $534,460	-2,000 Reduced 50.0%	2,000 $487,000
Q3 2022 Nov 10, 2022	SELL	$51.03 - $264.23 $107,163 - $554,883	-2,100 Reduced 34.43%	4,000 $891 Million
Q1 2022 May 04, 2022	SELL	$243.64 - $270.48 $6,091 - $6,762	-25 Reduced 0.41%	6,100 $1.62 Million
Q4 2021 Feb 02, 2022	BUY	$230.08 - $250.94 $5,752 - $6,273	25 Added 0.41%	6,125 $1.54 Million
Q3 2021 Nov 10, 2021	SELL	$232.72 - $256.47 $34,908 - $38,470	-150 Reduced 2.4%	6,100 $1.5 Million
Q1 2021 May 10, 2021	SELL	$232.09 - $256.88 $197,276 - $218,348	-850 Reduced 11.97%	6,250 $1.52 Million
Q4 2020 Feb 11, 2021	BUY	$221.92 - $245.94 $665,760 - $737,820	3,000 Added 73.17%	7,100 $1.78 Million
Q1 2020 Apr 30, 2020	SELL	$195.69 - $279.01 $261,637 - $373,036	-1,337 Reduced 24.59%	4,100 $942,000
Q3 2019 Nov 08, 2019	SELL	$230.58 - $256.08 $749,385 - $832,260	-3,250 Reduced 37.41%	5,437 $1.38 Million
Q1 2019 May 01, 2019	BUY	$206.05 - $248.17 $123,630 - $148,902	600 Added 7.42%	8,687 $2.17 Million
Q4 2018 Jan 31, 2019	SELL	$204.73 - $257.93 $135,735 - $171,007	-663 Reduced 7.58%	8,087 $1.82 Million
Q2 2017 Aug 09, 2017	BUY	N/A	8,750	8,750 $1.71 Million

Others Institutions Holding BDX

# of Institutions

1,739

Shares Held

248M

Call Options Held

687K

Put Options Held

788K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $69.9B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet & Cie (Europe) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet & Cie (Europe) Sa with notifications on news.

Account

Pictet & Cie (Europe) Sa Becton Dickinson & CO Transaction History